HLA DQ-DR haplotype and susceptibility to cervical carcinoma: Indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18

Tissue Antigens

Volumn 48, Issue 1, 1996, Pages 32-37

  Allen, M ^a   Kalantari, M ^b   Ylitalo, N ^a   Pettersson, B ^c   Hagmar, B ^d   Scheibenpflug, L ^c   Johansson, B ^b   Petterson, U ^a   Gyllensten, U ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

HLA DQ DR; HPV 18

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; HAPLOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SWEDEN; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS INFECTION; WART VIRUS;

EID: 0029836004     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02602.x     Document Type: Article

References (36)

1. Parkin DM, Läärä E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988: 41: 184.
2. Schiffman MH, Bauer HM, Hoover RN et al. Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Can Just 1993: 85: 958.
3. Crum CP, Nuovo G, Friedman D et al. In situ hybridization analysis of human papillomavirus 16 DNA sequences in early cervical neoplasia. Am J Pathol 1986: 123: 174.
4. Lorincz AT, Reid R, Jenson AB et al. Human papillomavirus infection of the cervix: relative risk association of 15 common anogenital types. Obstet Gynecol 1992: 79: 328.
5. Durst M, Gissman L, Ikenberg H et al. A papillomavirus from different geographic regions. Proc Natl Acad Sci USA 1983: 80: 3812.
6. Crum CP, Ikenberg HRMR, Gissman L. Human papillomavirus type 16 in early cervical neoplasia. N Engl J Med 1984: 310: 880.
7. Kurman RJ, Shiffman MH, Lancaster WD et al. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol 1988: 159: 293.
8. Brinton LA, Hamman RF, Huggins GR et al. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst 1987: 79: 23.
9. Brinton LA, Schairer C, Haenszel W et al. Smoking and invasive cervical cancer. JAMA 1986: 255: 3265.
10. Layde PM, Broste SK. Carcinoma of the cervix and smoking. Biomed Pharmacother 1989: 43: 161.
11. Becker TM, Wheeler CM, McGough NS et al. Cigarette smoking and other risk factors for cervical dysplasia in Southwestern hispanic and non-hispanic white women. Cancer Epidemiol Biomarkers 1994: 3: 113.
12. Zaninetti P, Franceschi S, Baccolo, M et al. Characteristics of women under 20 with cervical intraepithelial neoplasia. Int J Epidemiol 1986: 15: 477.
13. Morrison EAB, Ho GYF, Vermund SH et al. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 1991: 49: 6.
14. Kirchner H. Immunobiology of human papillomavirus infection. Prog Med Virol 1986: 33: 1.
15. Porreco R, Penn I, Droegemueller W et al. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol 1975: 45: 359.
16. Hilders CG, Houbiers JG, Krul EJ et al. The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma. Am J Clin Pathol 1994: 101: 5.
17. Honma S, Tsukada S, Honda S et al. Biological-clinical significance of selective loss of HLA-class-I allelic product expression in squamous-cell carcinoma of the uterine cervix. Int J Cancer 1994: 57: 650.
18. Gregoire L, Lawrence WD, Kukuruga D et al. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer 1994: 57: 504.
19. Helland Å, Borrensen A-L, Kristensen G et al. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: Relationship to human papillomavirus infection and prognosis. Cancer Epidemiol Biomarkers 1994: 3: 479.
20. Wank R, Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991: 352: 723.
21. Apple RJ, Erlich HA, Klitz W et al. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet 1994: 6: 157.
22. Glew SS, Stern PL, Davidson JA et al. Scientific correspondence. Nature 1992: 356: 22.
23. Glew SS, Duggan-Keen M, Ghosh AK et al. Lack of association of HLA polymorphisms with papillomavirus related cervical cancer. Hum Immunol 1993: 37: 157.
24. Bugawan TL, Erlich HA. Rapid typing of HLA-DQB1 DNA polymorphism using non-radioactive oligonucleotide probes and amplified DNA. Immunogenetics 1991: 33: 163.
25. Scharf SJ, Griffith RL, Erlich HA. Rapid typing of DNA sequence polymorphism at the HLA-DRB1 locus using the polymerase chain reaction and nonradioactive oligonucleotide probes. Hum Immunol 1991: 30: 190.
26. Marsh SGE, Bodmer JG. HLA class II nucleotide sequences. Tissue Antigens 1992: 40: 229.
27. Ylitalo N, Bergström T, Gyllensten U. Detection of genital HPV using a single tube nested-PCR system and type-specific nonradioactive oligonucleotide hybridization. J Clin Microbiol 1995: 33: 1822.
28. Woolf B. On estimating the relation between blood groups and disease. Ann Hum Genet 1955: 19: 251.
29. Haldane JBS. The estimation and significance of the logarithm of ratio frequencies. Ann Hum Genet 1956: 20: 309.
30. Evander M, Edlund K, Boden E et al. Comparison of a one-step and a two-step polymerase chain reaction with degenerate primers in a population-based study of human papillomavirus infection in young Swedish women. Clin Microbiol 1992: 30: 987.
31. Allen M, Saldeen T, Pettersson U et al. Genetic typing of HLA class II genes in Swedish populations: application to forensic analysis. J For Sci 1993: 38: 554.
32. Bosch FX, Munos N, Sanjose S et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/ carcinoma in situ: a case control study in Spain and Colombia. Can Epidemiol Biomarkers 1993: 2: 415.
33. Munoz N, Bosch FX, de Sanjosé, S et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers 1993: 2: 423.
34. Scheffner M, Werness BA, Huibregtse JM et al. The E6 oncoprotein encoded by human papillomavirus 16 or 18 promotes degradation of p53. Cell 1990: 63: 1129.
35. Werness BA, Levine AJ, Howley PM et al. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990: 248: 76.
36. Strang G, Hickling JK, McIndoe, GAJ et al. Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. J Gen Virol 1990: 71: 423.